Newborn affected by maternal use of antidepressants

This code identifies a newborn who exhibits signs or symptoms attributable to the mother's therapeutic use of antidepressant medications during pregnancy. It signifies the infant's physiological response or withdrawal symptoms resulting from in utero exposure. This includes conditions such as neonatal abstinence syndrome (NAS) specifically linked to antidepressant exposure.

Apply this code when documentation clearly indicates a newborn is affected by maternal antidepressant use, evidenced by clinical signs observed in the infant. This typically occurs when the mother has a documented history of antidepressant prescription and the infant presents with symptoms like tremors, irritability, feeding difficulties, or respiratory distress shortly after birth. Documentation should specify the maternal medication and the infant's related clinical presentation.

• Always sequence this code as a secondary diagnosis, following the code for the specific neonatal condition or symptom (e.g., neonatal withdrawal syndrome).
• Ensure documentation explicitly links the newborn's symptoms to maternal antidepressant use, not other substances.
• Do not use this code if the mother's antidepressant use was illicit or recreational; use codes from category P04.4- for those scenarios.